Skip to main content

Table 3 Clinical factors for TBR ≥ 1% analyzed by multivariate logistic regression analysis

From: The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study

 

Odds ratio

95% CI

P value

CV

 Insulin treatment

1.49

0.54–4.13

0.4426

 History of stroke or TIA

1.59

0.41–6.25

0.5056

 HbA1c

1.17

0.45–3.13

0.7548

 FPG

0.99

0.97–1.00

0.1420

 CPI

1.09

0.67–1.92

0.7408

 CV

1.43

1.28–1.65

< 0.0001

 TAR

0.90

0.84–0.95

0.0005

SD

 Insulin treatment

1.76

0.68–4.54

0.2398

 History of stroke or TIA

1.58

0.44–5.66

0.4856

 HbA1c

0.99

0.42–2.33

0.9757

 FPG

0.99

0.97–1.00

0.0956

 CPI

1.03

0.65–1.71

0.8929

 SD

1.27

1.17–1.41

< 0.0001

 TAR

0.79

0.71–0.86

< 0.0001

MAGE

 Insulin treatment

2.35

0.93–5.94

0.0720

 History of stroke or TIA

2.08

0.59–7.35

0.2535

 HbA1c

1.13

0.51–2.53

0.7611

 FPG

0.98

0.97–1.00

0.0850

 CPI

0.90

0.57–1.45

0.6560

 MAGE

1.07

1.04–1.10

< 0.0001

 TAR

0.84

0.78–0.90

< 0.0001

  1. TIA transient ischemic attack, FPG fasting plasma glucose, CPI C-peptide index, CV coefficient of variation, SD standard deviation, MAGE mean amplitude of glycemic excursions, CI confidence interval, TAR time above target glucose range, TBR time below target glucose range
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us